Drug Development Market Research Reports & Industry Analysis
The drug development industry is dedicated to creating and refining treatments that improve lives and combat diseases. This field is in a state of rapid transformation, driven by advances in technology, regulatory changes, and shifting patient needs. MarketResearch.com provides hundreds of drug development industry reports to allow stakeholders to understand important market trends, challenges, and opportunities with unparalleled clarity.
Drug Development Market Research and Industry Forecasts
- Our wide-ranging reports cover a variety of dynamic markets and provide drug development market size and growth forecasts.
- Additionally, our research includes pipeline assessments of clinical trial products and clinical developments, value chain analysis, price indicators, and more.
- The competitive landscape is also covered in detail, with information on market structure, key players, company overviews, product portfolios, financials, and SWOT analyses.
MarketResearch.com: Your Dedicated Partner
Designed with consultants and busy executives in mind, our reports are powerful tools for enhancing your decision-making process. Our research can help you anticipate market changes and seize emerging opportunities as the drug development industry continues to evolve. Browse our full list of drug development market research reports to get started.
Drug Development Industry Research & Market Reports
-
Cloud-Based Drug Discovery Platforms
... 2030, growing at a CAGR of 14.3% over the analysis period 2024-2030. Pharmaceutical Vendors End-Use, one of the segments analyzed in the report, is expected to record a 15.1% CAGR and reach US$3.0 Billion by ... Read More
-
Organs-on-Chips
... 35.3% over the analysis period 2024-2030. Liver, one of the segments analyzed in the report, is expected to record a 36.6% CAGR and reach US$206.0 Billion by the end of the analysis period. Growth in ... Read More
-
Peptide Synthesis
... CAGR of 4.3% over the analysis period 2024-2030. Reagent, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$161.7 Million by the end of the analysis period. ... Read More
-
Drug Discovery Informatics
... at a CAGR of 9.6% over the analysis period 2024-2030. Software Component, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$3.4 Billion by the end of ... Read More
-
MRSA Drugs
... CAGR of 4.5% over the analysis period 2024-2030. Glycopeptides & Lipoglycopeptides, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$726.5 Million by the end of the ... Read More
-
Fragment-based Drug Discovery
... at a CAGR of 8.8% over the analysis period 2024-2030. Fragment Screening, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$1.1 Billion by the end of ... Read More
-
Single-Use Bioprocessing
... CAGR of 20.8% over the analysis period 2024-2030. Single-Use Media Bags & Containers, one of the segments analyzed in the report, is expected to record a 22.6% CAGR and reach US$29.9 Billion by the end ... Read More
-
Viral Clearance
... CAGR of 18.2% over the analysis period 2024-2030. Recombinant Proteins, one of the segments analyzed in the report, is expected to record a 18.5% CAGR and reach US$467.7 Million by the end of the analysis ... Read More
-
mRNA Platform
... CAGR of -2.7% over the analysis period 2024-2030. Covid-19 Vaccine, one of the segments analyzed in the report, is expected to record a -6.3% CAGR and reach US$102.1 Billion by the end of the analysis ... Read More
-
Biomarkers Market Report by Product (Consumables, Services, Software), Type (Efficacy Biomarkers, Safety Biomarkers, Validation Biomarkers), Disease (Cancer, Cardiovascular Disorders, Neurological Disorders, Immunological Disorders, Renal Disorders, and Others), Application (Diagnostics, Drug Discovery and Development, Personalized Medicine, and Others), End User (Pharmaceutical and Biotechnology Companies, Diagnostic and Research Laboratories, Hospitals and Specialty Clinics, and Others), and Region 2025-2033
... rising prevalence of chronic diseases, ongoing developments in biotechnology and genomics, the shift toward personalized medicine, continuous advancements in analytical technologies, and increasing awareness among both healthcare professionals and patients about the benefits of biomarkers ... Read More
-
Pathology Instruments
... CAGR of 5.6% over the analysis period 2024-2030. Molecular Diagnostics, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$1.7 Billion by the end of the analysis ... Read More
-
Small Molecule Drug Discovery
... 2030, growing at a CAGR of 8.4% over the analysis period 2024-2030. Oncology Therapeutic Area, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$38.9 Billion by ... Read More
-
Drug Discovery Outsourcing
... at a CAGR of 6.5% over the analysis period 2024-2030. Lead Identification & Candidate Optimization, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$3.0 Billion by ... Read More
-
Live Cell Encapsulation
... at a CAGR of 3.8% over the analysis period 2024-2030. Alginate, one of the segments analyzed in the report, is expected to record a 4.4% CAGR and reach US$117.8 Million by the end of the ... Read More
-
20s Proteasome Inhibitor - Pipeline Insight, 2025
... pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental ... Read More
-
Cancer Immunotherapy Drug Discovery Outsourcing
... Billion by 2030, growing at a CAGR of 14.0% over the analysis period 2024-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 13.4% CAGR and reach US$1.5 Billion ... Read More
-
Antivirals Drug
... CAGR of 4.2% over the analysis period 2024-2030. DNA Polymerase Inhibitors, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$14.7 Billion by the end of the ... Read More
-
Hepatitis C Treatment
... at a CAGR of 10.7% over the analysis period 2024-2030. HCV Protease Inhibitors, one of the segments analyzed in the report, is expected to record a 9.2% CAGR and reach US$25.3 Billion by the end ... Read More
-
Stable Isotope Labeled Compounds
... 2030, growing at a CAGR of 3.9% over the analysis period 2024-2030. Deuterium, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$183.4 Million by the end ... Read More
-
Label-free Array Systems
... at a CAGR of 5.6% over the analysis period 2024-2030. Surface Plasmon Resonance (SPR), one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.8 Billion by the ... Read More
-
Gynecological Cancer Drugs
... at a CAGR of 5.1% over the analysis period 2024-2030. Targeted Therapy, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$12.1 Billion by the end of ... Read More
-
Cancer Immunotherapy Drug Discovery Outsourcing Global Market Report 2025
... immunotherapy drug discovery outsourcing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain ... Read More
-
Protein Detection & Quantification Market Report by Product (Kits and Reagents/Consumables, Instruments, Services), Technology (Colorimetric Assays, Immunological Methods, Chromatography, Mass Spectrometry, Spectroscopy Instruments, and Others), Application (Drug Discovery and Development, Clinical Diagnosis, and Others), End User (Academic Research Institutes, Biotechnology and Pharmaceutical Companies, Contract Research Organization, and Others), and Region 2025-2033
... during 2025-2033. The market is experiencing steady growth driven by the increasing emphasis on personalized medicine, rising need for proteomics research to uncover novel insights into protein functions, interactions, and post-translational modifications and the escalating ... Read More
-
G-Protein Coupled Receptor (GPCR) Agonist - Pipeline Insight, 2025
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
High Content Screening Market by Product & Services (Instrument (Cell Imaging, Analysis System), Consumables (Reagents & Assay Kits, Microplates), Software), Application (Drug Discovery & Development, Toxicology), End User - Global Forecast to 2030
... owing to the innovations in high-resolution imaging, automation, and artificial intelligence (AI)-powered data analysis, which have significantly enhanced the efficiency and accuracy of HCS workflows. Advanced instruments equipped with high-speed fluorescence microscopy, confocal imaging, and ... Read More
Research Assistance
